Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
16-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.4
advertisement
11.4 Prostaglandins
(148)
Showing records 1 to 25
Display all abstracts in classification
11.4 Prostaglandins
Search within classification 11.4 Prostaglandins
60251
A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension
Natt NK
Indian Journal of Ophthalmology
2014; 62: 1136-1140
60097
Stability of Latanoprost in Generic Formulations Using Controlled Degradation and Patient Usage Simulation Studies
Velpandian T
Current Eye Research
2015; 40: 561-571
60524
Comparison of the Toxicity Profile of Benzalkonium Chloride-Preserved Tafluprost and SofZia-Preserved Travoprost Applied to the Ocular Surface
Kanamoto T
Journal of Ocular Pharmacology and Therapeutics
2015; 31: 156-164
60821
Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)
Ge J
Chinese Journal of Ophthalmology
2015; 51: 95-102
60458
Prostaglandin agonist effect on matrix metalloproteinase aqueous levels in glaucoma patients
Pradhan ZS
Canadian Journal of Ophthalmology
2015; 50: 6-10
60083
A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study
Weinreb RN
British Journal of Ophthalmology
2015; 99: 738-745
60630
Usability of prostaglandin monotherapy eye droppers
Drew T
British Journal of Ophthalmology
2015; 99: 1251-1254
60467
Impact of the introduction of generic latanoprost on glaucoma medication adherence
Stein JD
Ophthalmology
2015; 122: 738-747
60159
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
Garway-Heath DF
Lancet
2015; 385: 1295-1304
60569
Effect of topical prostaglandin analogues on corneal hysteresis
Bolívar G
Acta Ophthalmologica
2015; 93: e495-e498
60168
Original preparations versus generics--latanoprost: how similar is different?
Leitritz MA
Ophthalmologe
2015; 112: 127-139
60682
Influence of local application of glaucoma medications-travoprost eye drops on patients' tear film function
Zhang C
Pakistan journal of pharmaceutical sciences
2015; 28: 781-784
60477
Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
Kocabeyoglu S
Indian Journal of Ophthalmology
2015; 63: 15-19
60391
Time Course of Prostaglandin Analog-related Conjunctival Hyperemia and the Effect of a Nonsteroidal Anti-inflammatory Ophthalmic Solution
Sakata R
Journal of Glaucoma
2016; 25: e204-e208
60232
Prostaglandin-associated periorbitopathy in latanoprost users
Nakakura S
Clinical Ophthalmology
2015; 9: 51-56
59909
The circadian changes of intraocular pressure and ocular perfusion pressure after tafluprost compared with travoprost in normal tension glaucoma
Shin J
Journal of Ocular Pharmacology and Therapeutics
2014; 30: 803-809
60092
The Interaction of Nepafenac and Prostaglandin Analogs in Primary Open-angle Glaucoma Patients
Ozyol P
Journal of Glaucoma
2016; 25: e145-e149
60669
Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
Shimizu Y
Clinical Ophthalmology
2015; 9: 475-482
60150
Excipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells
Smedowski A
Journal of biochemical and pharmacological research
2014; 2: 175-184
60287
Medical therapy for glaucoma: what to add after a prostaglandin analogs?
Tanna AP
Current Opinions in Ophthalmology
2015; 26: 116-120
60508
Association between SNPs of Metalloproteinases and Prostaglandin F2α Receptor Genes and Latanoprost Response in Open-Angle Glaucoma
Ussa F
Ophthalmology
2015; 122: 1040-8.e4
60577
Periocular skin hyperpigmentation in children treated with prostaglandin analogues
Al-Zobidi M
Journal of AAPOS
2015; 19: 49-53
60425
Prostaglandin analogue-induced pigmentation of the skin of the nasal septum and nasal alae in a glaucoma patient
Holló G
European Journal of Ophthalmology
2015; 0: 0
60317
Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Rossetti L
BMC Ophthalmology
2015; 15: 7
60558
Observations on Prostaglandin Orbitopathy
Custer PL
Ophthalmic Plastic and Reconstructive Surgery
2016; 32: 102-105
«
1
2
3
4
5
»
Issue
16-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement